Literature DB >> 24678782

Endoscopic endonasal surgery for suprasellar meningiomas: experience with 75 patients.

Maria Koutourousiou1, Juan C Fernandez-Miranda, S Tonya Stefko, Eric W Wang, Carl H Snyderman, Paul A Gardner.   

Abstract

OBJECT: Following the introduction of the neurosurgical microscope, the outcomes in suprasellar meningioma surgery were dramatically improved. More recently, the neurosurgical endoscope has been introduced as a visualization option during removal of skull base tumors, both transcranially and endonasally. The authors retrospectively reviewed the effectiveness of endoscopic endonasal surgery (EES) in the management of suprasellar meningiomas.
METHODS: Between 2002 and 2011, 75 patients (81.3% female) with suprasellar meningiomas underwent EES at the University of Pittsburgh Medical Center. The authors present the results of EES and analyze the resection rates, visual outcome, and complications.
RESULTS: Seventy-one patients presented with primary tumors, whereas 4 were previously treated elsewhere. Their mean age was 57.3 years (range 36-88 years), and most patients presented with visual loss (81.3%). Tumors occupied the tuberculum sellae (86.7%) and planum sphenoidale (50.7%), with extension into the optic canals in 26.7% (unilateral in 21.3% and bilateral in 5.3%) and the pituitary fossa (9.3%). Gross-total tumor resection (Simpson Grade I) was achieved in 76% of the cases in the whole cohort and in 81.4% of the patients in whom it was the goal of surgery. Tumor location and extension into the optic canals was not a limitation for total resection. Tumor size, configuration, and vascular encasement were significant factors that influenced the degree of resection (p < 0.0001). Vision was improved or normalized in 85.7% of the cases. Visual deterioration following EES occurred in 2 patients (3.6%). Complications included postoperative CSF leaks (25.3% overall, 16.1% in recent years) resulting in meningitis in 4 cases. One patient had an intraoperative injury of the artery of Heubner resulting in associated neurological deficit. Another elderly patient died within 1 month after EES due to cerebral vasospasm and multisystem impairment. No patient developed postoperative cerebral contusions, hemorrhage, or seizures. During a mean follow-up period of 29 months (range 1-98 months), 4 patients have shown recurrence, but only 1 required repeat EES.
CONCLUSIONS: With the goal of gross-total tumor resection and visual improvement, EES can achieve very good results, (comparable to microscopic approaches) for the treatment of suprasellar meningiomas. Avoidance of brain and optic nerve retraction, preservation of the vascularization of the optic apparatus, and wide decompression of the optic canals are the main advantages of EES for the treatment of suprasellar meningiomas, while CSF leaks remain a disadvantage.

Entities:  

Keywords:  ACA = anterior cerebral artery; EEA = endoscopic endonasal approach; EES = endoscopic endonasal surgery; GTR = gross-total resection; SIADH = syndrome of inappropriate antidiuretic hormone; endoscopic endonasal surgery; endoscopic skull base surgery; meningiomas; planum; suprasellar; tuberculum sellae

Mesh:

Year:  2014        PMID: 24678782     DOI: 10.3171/2014.2.JNS13767

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  36 in total

Review 1.  Comprehensive review on rhino-neurosurgery.

Authors:  Werner Hosemann; Henry W S Schroeder
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

2.  The Endoscopic Endonasal Management of Anterior Skull Base Meningiomas.

Authors:  Matteo Zoli; Federica Guaraldi; Ernesto Pasquini; Giorgio Frank; Diego Mazzatenta
Journal:  J Neurol Surg B Skull Base       Date:  2018-08-27

Review 3.  Endoscopic transnasal skull base surgery: pushing the boundaries.

Authors:  Nathan T Zwagerman; Georgios Zenonos; Stefan Lieber; Wei-Hsin Wang; Eric W Wang; Juan C Fernandez-Miranda; Carl H Snyderman; Paul A Gardner
Journal:  J Neurooncol       Date:  2016-10-20       Impact factor: 4.130

4.  Meningioma recurrence rates following treatment: a systematic analysis.

Authors:  Victor Lam Shin Cheung; Albert Kim; Arjun Sahgal; Sunit Das
Journal:  J Neurooncol       Date:  2017-11-15       Impact factor: 4.130

5.  Cerebrospinal fluid leaks in extended endoscopic transsphenoidal surgery: covering all the angles.

Authors:  Hussein Fathalla; Antonio Di Ieva; John Lee; Jennifer Anderson; Rowan Jing; Michael Solarski; Michael D Cusimano
Journal:  Neurosurg Rev       Date:  2016-08-24       Impact factor: 3.042

6.  Total Human Eye Allotransplantation: Developing Surgical Protocols for Donor and Recipient Procedures.

Authors:  Edward H Davidson; Eric W Wang; Jenny Y Yu; Juan C Fernandez-Miranda; Dawn J Wang; Nikisha Richards; Maxine Miller; Joel S Schuman; Kia M Washington
Journal:  Plast Reconstr Surg       Date:  2016-12       Impact factor: 4.730

7.  The extended, transnasal, transsphenoidal approach for anterior skull base meningioma: considerations in patient selection.

Authors:  Joseph P Castlen; David J Cote; Hasan A Zaidi; Edward R Laws
Journal:  Pituitary       Date:  2017-10       Impact factor: 4.107

8.  Lateral supraorbital versus pterional approach for parachiasmal meningiomas: surgical indications and esthetic benefits.

Authors:  Hun Ho Park; Kyoung Su Sung; Ju Hyung Moon; Eui Hyun Kim; Sun Ho Kim; Kyu-Sung Lee; Chang-Ki Hong; Jong Hee Chang
Journal:  Neurosurg Rev       Date:  2019-08-03       Impact factor: 3.042

9.  Endoscopic transnasal surgery for planum and tuberculum sella meningiomas: decision-making, technique and outcomes.

Authors:  Varun R Kshettry; Khaled Elshazly; James J Evans
Journal:  CNS Oncol       Date:  2016-07-20

10.  Reconstruction of skull base bone defects using an in situ bone flap after endoscopic endonasal transplanum-transtuberculum approaches.

Authors:  Biao Jin; Xiao-Shu Wang; Gang Huo; Jia-Min Mou; Gang Yang
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-03-16       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.